Get the Stockscreener App
59.76
0.18%
0.11
Inspire Medical Systems Inc stock is traded at $59.76, with a volume of 1.89M.
It is up +0.18% in the last 24 hours and down -35.37% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
See More
Previous Close:
$59.65
Open:
$59.64
24h Volume:
1.89M
Relative Volume:
1.18
Market Cap:
$1.71B
Revenue:
$861.31M
Net Income/Loss:
$53.12M
P/E Ratio:
34.62
EPS:
1.7262
Net Cash Flow:
$85.01M
1W Performance:
-9.04%
1M Performance:
-35.37%
6M Performance:
-31.59%
1Y Performance:
-68.07%
1-Day Range:
$59.64
$63.50
1-Week Range:
$53.11
$71.16
52-Week Range:
$53.11
$197.75
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
59.76 | 1.70B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Inspire Medical Systems Inc. (INSP) Confronts Near-Term Headwinds Despite Profitability - Insider Monkey
10 Best Medical Technology Stocks to Invest In - Insider Monkey
Is Inspire Medical Systems Inc. stock dividend yield sustainableTrade Analysis Summary & Community Verified Trade Signals - mfd.ru
Why is Inspire Medical Systems Inc. stock going downRate Hike & Community Trade Idea Sharing Platform - mfd.ru
Can Inspire Medical Systems Inc. (2DR) stock retain market dominanceJuly 2025 Gainers & Stock Timing and Entry Methods - mfd.ru
Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook - MSN
Technical Reactions to INSP Trends in Macro Strategies - Stock Traders Daily
Inspire Medical Systems, Inc. Just Beat EPS By 401%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Results: Inspire Medical Systems, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Thrivent Financial for Lutherans Has $1.44 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc.INSP - PR Newswire
Inspire Medical Systems, Inc. SEC 10-K Report - TradingView
INSP Downgraded to Peer Perform by Wolfe Research | INSP Stock N - GuruFocus
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
6.4 Million Medicare Recipients Face New Hurdles in Getting Care - AOL.com
Inspire Medical Systems (NYSE:INSP) Downgraded to Hold Rating by Robert W. Baird - MarketBeat
Inspire Medical Systems (NYSE:INSP) Lowered to "Hold" Rating by Wells Fargo & Company - MarketBeat
Wolfe Research downgrades Inspire Medical Systems stock rating to Peerperform - Investing.com Canada
Inspire Medical Systems stock hits 52-week low at $56.17 By Investing.com - Investing.com Canada
Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns - Investing.com Nigeria
Baird downgrades Inspire Medical stock to Neutral on reimbursement concerns - Investing.com Nigeria
What the FDA’s 2026 Update Means for Wearables - AOL.com
Jefferies Lowers Price Target for INSP, Keeps Hold Rating | INSP Stock News - GuruFocus
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $66.00 by Analysts at Jefferies Financial Group - MarketBeat
Analyst Shagun Singh Maintains Rating for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus
Stifel lowers Inspire Medical Systems stock price target on reimbursement issues - Investing.com Canada
Inspire Medical: Still A Long Way From A Good Night’s Sleep (NYSE:INSP) - Seeking Alpha
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz
Inspire Medical Systems Lowers FY2026 Revenue Guidance After CMS Coding Clarification, Oppenheimer Says - marketscreener.com
INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) Shares Gap Down on Analyst Downgrade - MarketBeat
Piper Sandler Lowers Price Target for INSP to $85, Maintains Ove - GuruFocus
Wells Fargo Downgrades INSP to Equal-Weight, Lowers Price Target - GuruFocus
INSP: Mizuho Lowers Price Target to $85, Maintains Outperform Ra - GuruFocus
Inspire Medical Systems stock hits 52-week low at $56.17 - Investing.com
INSP Q4 Deep Dive: Reimbursement Uncertainty Shapes Outlook Despite Strong Product Adoption - Finviz
This Inspire Medical Systems Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Truist Cuts Price Target on Inspire Medical Systems to $70 From $96, Keeps Hold Rating - marketscreener.com
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $70.00 by Analysts at Truist Financial - MarketBeat
Inspire Medical Systems (NYSE:INSP) Given New $85.00 Price Target at Piper Sandler - MarketBeat
Mizuho Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 earnings call transcript - MSN
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Inspire Medical Systems to $68 From $90, Keeps Sector Perform Rating - marketscreener.com
Baird Downgrades Inspire Medical Systems to Neutral From Outperform, Adjusts Price Target to $74 From $130 - marketscreener.com
Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns By Investing.com - Investing.com India
What 19 Analyst Ratings Have To Say About Inspire Medical Systems - Benzinga
Inspire Medical Stock Pre-Market (-8.7%) : Weak 2026 Revenue Guidance - Trefis
Baird Downgrades Inspire Medical Systems (INSP) and Lowers Price Target | INSP Stock News - GuruFocus
Wells Fargo downgrades Inspire Medical Systems stock rating on reimbursement concerns - Investing.com India
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):